Market Research Logo

Canada Intraocular Lens (IOL) Market Outlook to 2022

Canada Intraocular Lens (IOL) Market Outlook to 2022

Summary

GlobalData’s new report, Canada Intraocular Lens (IOL) Market Outlook to 2022, provides key market data on the Canada Intraocular Lens (IOL) market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segements - Foldable IOL and Polymethyl Methacrylate (PMMA) IOL.

The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Intraocular Lens (IOL) market segements - Foldable IOL and Polymethyl Methacrylate (PMMA) IOL.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.
  • 2015 company shares and distribution shares data for each of the market segements.
  • Global corporate-level profiles of key companies operating within the Canada Intraocular Lens (IOL) market.
  • Key players covered include Alcon, Inc., Abbott Medical Optics, Inc., Bausch & Lomb Incorporated, Carl Zeiss AG and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Intraocular Lens (IOL) Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Intraocular Lens (IOL) Market, Canada
3.1 Intraocular Lens (IOL) Market, Canada, Revenue ($m), 2008-2015
3.2 Intraocular Lens (IOL) Market, Canada, Revenue ($m), 2015-2022
3.2.1 Foldable IOL Market, Canada, Revenue ($m), by Segment, 2008-2015
3.2.2 Foldable IOL Market, Canada, Revenue ($m), by Segment, 2015-2022
3.3 Intraocular Lens (IOL) Market, Canada, Volume (Units), 2008-2015
3.4 Intraocular Lens (IOL) Market, Canada, Volume (Units), 2015-2022
3.4.1 Foldable IOL Market, Canada, Volume (Units), by Segment, 2008-2015
3.4.2 Foldable IOL Market, Canada, Volume (Units), by Segment, 2015-2022
3.5 Intraocular Lens (IOL) Market, Canada, Average Price ($), 2008-2022
3.6 Intraocular Lens (IOL) Market, Canada, Distribution Share by Revenue ($m), 2014-2015
3.7 Intraocular Lens (IOL) Market, Canada, Company Share by Revenue ($m), 2015
4 Overview of Key Companies in Canada, Intraocular Lens (IOL) Market
4.1 Abbott Medical Optics, Inc.
4.1.1 Company Overview
4.2 Bausch & Lomb Incorporated
4.2.1 Company Overview
4.3 Hoya Corporation
4.3.1 Company Overview
4.4 Carl Zeiss AG
4.4.1 Company Overview
4.5 Alcon, Inc.
4.5.1 Company Overview
5 Intraocular Lens (IOL) Market Pipeline Products
6 Financial Deals Landscape
6.1 Private Equity
6.1.1 Valeant Pharma Rejects Joint Takeover Bid from Takeda Pharma and TPG Capital Management
7 Recent Developments
7.1 Corporate Communications
7.1.1 Oct 06, 2016: Valeant Appoints Louis W. Yu, Ph.D. As Chief Quality Officer
7.1.2 Aug 22, 2016: Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer
7.1.3 Aug 08, 2016: Valeant Pharmaceuticals Announces Changes To Executive Management Team
7.1.4 Jul 28, 2016: Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors
7.1.5 Jun 15, 2016: Valeant Pharmaceuticals Appoints Thomas W. Ross, Sr. Lead Independent Director
7.1.6 May 26, 2016: Valeant Pharmaceuticals Names Sam Eldessouky Senior Vice President And Corporate Controller
7.1.7 May 03, 2016: Joseph C. Papa Assumes Role Of Chairman And Chief Executive Officer Of Valeant Pharmaceuticals
7.1.8 Apr 29, 2016: Valeant Announces Nominees For Election To Board Of Directors
7.1.9 Apr 25, 2016: Valeant Names Joseph C. Papa To Be Chairman And Chief Executive Officer Of Valeant Pharmaceuticals
7.1.10 Mar 21, 2016: Valeant Announces CEO Succession Plan And Changes To Board Of Directors
7.1.11 Mar 09, 2016: Valeant Pharmaceuticals Announces The Addition Of Three New Independent Directors To Its Board
7.1.12 Mar 02, 2016: Valeant Pharmaceuticals Announces Management Change
7.1.13 Feb 28, 2016: Valeant Pharmaceuticals Announces Management And Business Update
7.2 Financial Announcements
7.2.1 Nov 08, 2016: Valeant Reports Third Quarter 2016 Financial Results
7.2.2 Aug 09, 2016: Valeant Pharmaceuticals Reports Second Quarter 2016 Financial Results
7.2.3 Jun 07, 2016: Valeant Pharmaceuticals Reports First Quarter 2016 Financial Results
7.2.4 Mar 15, 2016: Valeant Pharmaceuticals Reports Preliminary Unaudited Fourth Quarter 2015 Financial Information
7.3 Legal And Regulatory
7.3.1 Aug 10, 2016: Valeant Pharmaceuticals Comments On SDNY Investigation
7.3.2 Mar 09, 2016: Valeant And R&O Pharmacy End Litigation
7.4 Other Significant Developments
7.4.1 Jun 17, 2016: Valeant Pharmaceuticals Announces Significant Investments In Canadian Operations
7.4.2 May 16, 2016: Valeant Pharmaceuticals Provides Update on Regulatory Matters
7.4.3 Apr 13, 2016: Valeant Pharmaceuticals Provides Update Regarding Regulatory Matters
7.4.4 Mar 21, 2016: Valeant Provides Accounting And Financial Reporting Update
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Company Share Analysis
8.1.5 Distribution Share Analysis
8.1.6 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
1.1 List of Tables
Table 1: Intraocular Lens (IOL) Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015
Table 2: Intraocular Lens (IOL) Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 3: Foldable IOL Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015
Table 4: Foldable IOL Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 5: Intraocular Lens (IOL) Market, Canada, Volume (Units), Historic, 2008-2015
Table 6: Intraocular Lens (IOL) Market, Canada, Volume (Units), Forecast, 2015-2022
Table 7: Foldable IOL Market, Canada, Volume (Units), Historic, 2008-2015
Table 8: Foldable IOL Market, Canada, Volume (Units), Forecast, 2015-2022
Table 9: Intraocular Lens (IOL) Market, Canada, Average Price ($) Historic, 2008-2022
Table 10: Intraocular Lens (IOL) Market, Canada, Average Price ($), Forecast, 2015-2022
Table 11: Intraocular Lens (IOL) Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2014-2015
Table 12: Intraocular Lens (IOL) Market, Canada, Company Share by Revenue ($m), USD Constant, 2015
Table 13: Intraocular Lens (IOL) Market Pipeline Products
Table 14: Valeant Pharma Rejects Joint Takeover Bid from Takeda Pharma and TPG Capital Management
1.2 List of Figures
Figure 1: Intraocular Lens (IOL) Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 2: Intraocular Lens (IOL) Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 3: Foldable IOL Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 4: Foldable IOL Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 5: Intraocular Lens (IOL) Market, Canada, Volume (Units), Historic, 2008-2015
Figure 6: Intraocular Lens (IOL) Market, Canada, Volume (Units), Forecast, 2015-2022
Figure 7: Foldable IOL Market, Canada, Volume (Units), Historic, 2008-2015
Figure 8: Foldable IOL Market, Canada, Volume (Units), Forecast, 2015-2022
Figure 9: Intraocular Lens (IOL) Market, Canada, Company Share (%) 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report